{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Combined+Hyperlipidemia&page=2", "query": { "condition": "Combined Hyperlipidemia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 71, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Combined+Hyperlipidemia&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Combined+Hyperlipidemia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-30T10:32:16.820Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01163851", "title": "Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypercholesterolemia", "Dyslipidemia" ], "interventions": [ { "name": "4 mg/kg", "type": "BIOLOGICAL" }, { "name": "0.5 mg/kg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 25, "start_date": "2010-07", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2018-03-01", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 5, "location_summary": "Peoria, Arizona • Phoenix, Arizona • Overland Park, Kansas", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01163851" }, { "nct_id": "NCT00459745", "title": "A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Combined Hyperlipidemia" ], "interventions": [ { "name": "Pravafen", "type": "DRUG" }, { "name": "Pravastatin", "type": "DRUG" }, { "name": "Fenofibrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shionogi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 481, "start_date": "2007-04", "completion_date": "2009-07", "has_results": false, "last_update_posted_date": "2018-04-24", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 57, "location_summary": "Phoenix, Arizona • Sierra Vista, Arizona • Long Beach, California + 46 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sierra Vista", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00459745" }, { "nct_id": "NCT01105975", "title": "A Study of LY2484595 in Patients With High LDL-C or Low HDL-C", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "LY2484595", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Simvastatin", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Placebo for LY2484595", "type": "DRUG" }, { "name": "Placebo for Statins", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 398, "start_date": "2010-04", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2018-03-22", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 38, "location_summary": "Fayetteville, Arkansas • San Diego, California • Spring Valley, California + 35 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Vista", "state": "California" }, { "city": "Golden", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01105975" }, { "nct_id": "NCT00134238", "title": "Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Mixed Hyperlipidemia" ], "interventions": [ { "name": "torcetrapib/atorvastatin", "type": "DRUG" }, { "name": "atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 755, "start_date": "2003-11", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2012-02-17", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 40, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 37 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Alhambra", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00134238" }, { "nct_id": "NCT01380730", "title": "LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperlipidemia" ], "interventions": [ { "name": "Evolocumab", "type": "BIOLOGICAL" }, { "name": "Placebo to Evolocumab", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 631, "start_date": "2011-07-01", "completion_date": "2012-04-05", "has_results": true, "last_update_posted_date": "2022-11-15", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Malvern, Arkansas + 48 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Malvern", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Carmichael", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01380730" }, { "nct_id": "NCT02278471", "title": "The SCCS Polypill Pilot Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension", "Hyperlipidemia" ], "interventions": [ { "name": "Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 303, "start_date": "2015-12", "completion_date": "2018-06-27", "has_results": true, "last_update_posted_date": "2021-05-14", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 1, "location_summary": "Mobile, Alabama", "locations": [ { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT02278471" }, { "nct_id": "NCT04770389", "title": "Randomized Study of Obicetrapib in Combination With Ezetimibe", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidemias", "High Cholesterol", "Hypercholesterolemia" ], "interventions": [ { "name": "Obicetrapib 5mg", "type": "DRUG" }, { "name": "Ezetimibe 10mg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "NewAmsterdam Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 112, "start_date": "2021-02-23", "completion_date": "2021-06-30", "has_results": true, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 3, "location_summary": "Lincoln, California • Evanston, Illinois • Houston, Texas", "locations": [ { "city": "Lincoln", "state": "California" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04770389" }, { "nct_id": "NCT07619131", "title": "A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolaemia" ], "interventions": [ { "name": "Laroprovstat", "type": "DRUG" }, { "name": "Rosuvastatin 1", "type": "DRUG" }, { "name": "Rosuvastatin 2", "type": "DRUG" }, { "name": "Laroprovstat/Rosuvastatin 1", "type": "DRUG" }, { "name": "Placebo to match rosuvastatin", "type": "DRUG" }, { "name": "Placebo to match Laroprovstat and Laroprovstat/Rosuvastatin 1", "type": "DRUG" }, { "name": "Laroprovstat/Rosuvastatin 2", "type": "DRUG" }, { "name": "Placebo to match Laroprovstat/Rosuvastatin 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 600, "start_date": "2026-08-12", "completion_date": "2027-07-30", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 77, "location_summary": "Dothan, Alabama • Chandler, Arizona • Phoenix, Arizona + 69 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07619131" }, { "nct_id": "NCT00267267", "title": "A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyperlipidemia", "Dyslipidemia" ], "interventions": [ { "name": "torcetrapib/atorvastatin", "type": "DRUG" }, { "name": "ezetimibe/simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1784, "start_date": "2006-01", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2007-12-10", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 123, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Mesa, Arizona + 100 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00267267" }, { "nct_id": "NCT00076518", "title": "The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections", "Hypertriglyceridemia" ], "interventions": [ { "name": "Fenofibrate", "type": "DRUG" }, { "name": "Fish Oil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": null, "completion_date": "2005-09", "has_results": false, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-09-30T10:32:16.820Z", "location_count": 5, "location_summary": "San Francisco, California • Atlanta, Georgia • Cincinnati, Ohio + 2 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT00076518" } ] }